A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
Nada A Ashour,1,* Ayman Abo Elmaaty,2,* Amany A Sarhan,3 Eslam B Elkaeed,4 Ahmed M Moussa,3 Ibrahim Ali Erfan,5 Ahmed A Al-Karmalawy3 1Department of Clinical Pharmacology, Faculty of Pharmacy, Horus University-Egypt, New Damietta, 34518, Egypt; 2Department of Medicinal Chemistry, Fac...
Main Authors: | Ashour NA, Abo Elmaaty A, Sarhan AA, Elkaeed EB, Moussa AM, Erfan IA, Al-Karmalawy AA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-03-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/a-systematic-review-of-the-global-intervention-for-sars-cov-2-combatin-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis
by: Wen Wen, et al.
Published: (2022-12-01) -
Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters
by: Éva Bakos, et al.
Published: (2023-07-01) -
Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
by: Ashley Jia Wen Yip, et al.
Published: (2022-06-01) -
Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge
by: Maen Abdelrahim, et al.
Published: (2022-04-01) -
Comparative evaluation of authorized drugs for treating Covid‐19 patients
by: Towhidul Islam, et al.
Published: (2022-07-01)